Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

San Diego • July 20, 2026 • 0 Views

SAN DIEGO, July 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on July 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (the "2026 Inducement Plan") as a material…

Source: https://www.gillettenewsrecord.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original

FB X ✉️

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!